Your browser doesn't support javascript.
loading
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade.
Srivastava, Shivani; Furlan, Scott N; Jaeger-Ruckstuhl, Carla A; Sarvothama, Megha; Berger, Carolina; Smythe, Kimberly S; Garrison, Sarah M; Specht, Jennifer M; Lee, Sylvia M; Amezquita, Robert A; Voillet, Valentin; Muhunthan, Vishaka; Yechan-Gunja, Sushma; Pillai, Smitha P S; Rader, Christoph; Houghton, A McGarry; Pierce, Robert H; Gottardo, Raphael; Maloney, David G; Riddell, Stanley R.
Afiliação
  • Srivastava S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: ssrivas2@fredhutch.org.
  • Furlan SN; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA.
  • Jaeger-Ruckstuhl CA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Sarvothama M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Berger C; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Smythe KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Garrison SM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Specht JM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Lee SM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Amezquita RA; Vaccine and Infections Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Voillet V; Vaccine and Infections Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Muhunthan V; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Yechan-Gunja S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Pillai SPS; Department of Comparative Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Rader C; Department of Immunology and Microbiology, Scripps Research Institute, Jupiter, FL, USA.
  • Houghton AM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Pierce RH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gottardo R; Vaccine and Infections Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.
Cancer Cell ; 39(2): 193-208.e10, 2021 02 08.
Article em En | MEDLINE | ID: mdl-33357452
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Receptores de Antígenos Quiméricos / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Receptores de Antígenos Quiméricos / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article